ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 92 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 6.67 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $117,854 | -19.2% | 19,480 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $145,787 | +73.6% | 18,787 | +19.7% | 0.00% | – |
| Q1 2022 | $84,000 | -66.0% | 15,697 | -6.6% | 0.00% | -100.0% |
| Q4 2021 | $247,000 | -31.8% | 16,802 | -2.9% | 0.00% | -50.0% |
| Q3 2021 | $362,000 | +24.0% | 17,305 | +4.7% | 0.00% | +100.0% |
| Q2 2021 | $292,000 | -9.9% | 16,534 | +25.2% | 0.00% | 0.0% |
| Q1 2021 | $324,000 | -25.9% | 13,207 | +2.4% | 0.00% | -50.0% |
| Q4 2020 | $437,000 | +236.2% | 12,898 | +147.7% | 0.00% | +100.0% |
| Q3 2020 | $130,000 | -27.8% | 5,207 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $180,000 | – | 5,325 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 4,768,181 | $161,403,000 | 14.64% |
| Invus Financial Advisors, LLC | 1,007,575 | $34,106,000 | 14.26% |
| Euclidean Capital LLC | 1,400,435 | $47,405,000 | 10.04% |
| Memorial Sloan Kettering Cancer Center | 602,272 | $20,387,000 | 8.63% |
| EcoR1 Capital, LLC | 3,092,218 | $104,672,000 | 5.63% |
| Ally Bridge Group (NY) LLC | 413,061 | $13,982,000 | 2.40% |
| Asymmetry Capital Management, L.P. | 67,210 | $2,275,000 | 1.04% |
| Orbimed Advisors | 2,921,967 | $98,909,000 | 0.86% |
| Casdin Capital, LLC | 601,515 | $20,361,000 | 0.60% |
| EMERALD ADVISERS, LLC | 522,302 | $17,680,000 | 0.59% |